No abstract available
MeSH terms
-
Azetidines / adverse effects
-
Azetidines / therapeutic use
-
Dermatitis, Atopic / drug therapy*
-
Dermatologic Agents / adverse effects
-
Dermatologic Agents / therapeutic use*
-
Heterocyclic Compounds, 3-Ring / adverse effects
-
Heterocyclic Compounds, 3-Ring / therapeutic use
-
Humans
-
Janus Kinase 1 / antagonists & inhibitors*
-
Janus Kinase 2 / antagonists & inhibitors*
-
Nitriles / adverse effects
-
Nitriles / therapeutic use
-
Purines / adverse effects
-
Purines / therapeutic use
-
Pyrazoles / adverse effects
-
Pyrazoles / therapeutic use
-
Pyrimidines / adverse effects
-
Pyrimidines / therapeutic use
-
Sulfonamides / adverse effects
-
Sulfonamides / therapeutic use
Substances
-
Azetidines
-
Dermatologic Agents
-
Heterocyclic Compounds, 3-Ring
-
Nitriles
-
Purines
-
Pyrazoles
-
Pyrimidines
-
Sulfonamides
-
upadacitinib
-
abrocitinib
-
ruxolitinib
-
JAK1 protein, human
-
JAK2 protein, human
-
Janus Kinase 1
-
Janus Kinase 2
-
baricitinib